Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1654

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 1654
---
 continuously renewing, and the duration is considered to be less than 24 hours, the Company measures
the transaction consideration at fair value on the date Bitcoin is received. The consideration is variable. The amount of consideration
recognized is constrained to the amount of consideration received, which is when it is probable a significant reversal will not occur.
There is no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations
and settlement of the transactions being on a daily basis.

Health
and Wellness Product Sales and Other Revenue

Through
our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty and wellness products.
We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete
when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects
the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board
(FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability
by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer
accounts receivable balances. As of December 31, 2024, deposits collected from customers for orders to be filled at a future date were
$1,014,164.

Shipping
and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility
located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included
in Cost of Sales and Service.

    F-11

INVESTVIEW,
INC.

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER
31, 2024 AND 2023

Cryptocurrency
Revenue

During
2023, we generated revenue from the sale of cryptocurrency packages to our customers through an arrangement with a third-party supplier.
The various packages included different amounts of coin with differing rates of returns and terms. The coin is delivered by a third-party
supplier. The sale of cryptocurrency packages was discontinued during the year ended December 31, 2023.

During
2023, we recognized cryptocurrency revenue in accordance with ASC 606-10 where revenue is measured based on a consideration specified
in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract